Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, following the non-fulfillment of a profit guarantee by Jiumei Xinhe, which reported a net profit significantly below expectations for the year ending March 2024. The disposal, classified as a discloseable transaction, does not require shareholders’ approval under Hong Kong’s Listing Rules. This move reflects the company’s efforts to streamline operations and focus on more profitable ventures.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.